-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GJs2zSk9PfBhsjtK4z2vmglHKPrU5yCsz430kfzNVOE6OtOwZuyZk5C5UeJk9cyH RvqRQX5ZykgmUbuI7oJPTw== 0001181431-08-065700.txt : 20081205 0001181431-08-065700.hdr.sgml : 20081205 20081205130708 ACCESSION NUMBER: 0001181431-08-065700 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080623 FILED AS OF DATE: 20081205 DATE AS OF CHANGE: 20081205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LANGE LOUIS G CENTRAL INDEX KEY: 0001238401 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21643 FILM NUMBER: 081232034 BUSINESS ADDRESS: BUSINESS PHONE: 6503848500 MAIL ADDRESS: STREET 1: 3172 PORTER DRIVE CITY: PALO ALTO STATE: CA ZIP: 94034 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CV THERAPEUTICS INC CENTRAL INDEX KEY: 0000921506 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 431570294 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3172 PORTER DR CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 6503848500 MAIL ADDRESS: STREET 1: 3172 PORTER DRIVE CITY: PALO ALTO STATE: CA ZIP: 94304 4 1 rrd221369.xml FORM 4 LOUIS G LANGE 092208 RSU DISTRIBUTION X0303 4 2008-06-23 0 0000921506 CV THERAPEUTICS INC CVTX 0001238401 LANGE LOUIS G 3172 PORTER DRIVE PALO ALTO CA 94304 1 1 0 0 Chairman & CEO Common Stock 2008-06-23 4 M 0 10052 0 A 280971 D Common Stock 2008-06-23 4 F 0 4453 8.39 D 276518 D Common Stock 2008-06-23 4 M 0 1294 0 A 277812 D Common Stock 2008-06-23 4 F 0 573 8.39 D 277239 D Common Stock 2008-09-22 4 M 0 10052 0 A 287291 D Common Stock 2008-09-22 4 F 0 4453 11.15 D 282838 D Common Stock 2008-09-22 4 M 0 1293 0 A 284131 D Common Stock 2008-09-22 4 F 0 572 11.15 D 285646 D Common Stock 4680.8935 I By 401(k) Restricted Stock Units 2008-06-23 4 M 0 10052 0 D 2005-12-22 2009-12-22 Common Stock 10052 100519 D Restricted Stock Units 2008-06-23 4 M 0 1294 0 D 2006-03-22 2009-12-22 Common Stock 1294 12934 D Restricted Stock Units 2008-09-22 4 M 0 10052 0 D 2005-12-22 2009-12-22 Common Stock 10052 90467 D Restricted Stock Units 2008-09-22 4 F 0 1293 0 D 2006-03-22 2009-12-22 1293 1293 11641 D Includes 1,300 shares acquired May 16, 2008 and 787 shares acquired August 15, 2008 pursuant to the CV Therapeutics, Inc. Employee Stock Purchase Plan ("ESPP"). Shares held in the Reporting Person's name in the Issuer's 401(k) plan. Upon payout, the Reporting Person is entitled to receive 1 share of common stock for each 1 restricted stock unit. 20,169 shares of this grant vested effective December 22, 2005; 5.554% of the shares of common stock subject to this grant shall vest at the end of each three month period (each a "Vesting Date") commencing on December 22, 2005, such that 100% of the shares of common stock subject to the restricted stock units are vested on December 22, 2009. Shares of common stock subject to any restricted stock units that vest shall be distributed to the Reporting Person in whole shares of common stock on each twelve (12) month anniversary of their relevant Vesting Date. The shares subject to this grant commenced vesting as of December 22, 2005; 6.25% of the shares of common stock subject to this grant shall vest at the end of each three month period (each a "Vesting Date") commencing on December 22, 2005, such that 100% of the shares of common stock subject to the restricted stock units are vested on December 22, 2009. Shares of common stock subject to any restricted stock units that vest shall be distributed to the Reporting Person in whole shares of common stock on each twelve (12) month anniversary of their relevant Vesting Date. Tricia Borga Suvari, Attorney-in Fact for : Louis G. Lange 2008-12-05 -----END PRIVACY-ENHANCED MESSAGE-----